321 related articles for article (PubMed ID: 37250804)
1. Genetically proxied impaired GIPR signaling and risk of 6 cancers.
Rogers M; Gill D; Ahlqvist E; Robinson T; Mariosa D; Johansson M; Cortez Cardoso Penha R; Dossus L; Gunter MJ; Moreno V; Davey Smith G; Martin RM; Yarmolinsky J
iScience; 2023 Jun; 26(6):106848. PubMed ID: 37250804
[TBL] [Abstract][Full Text] [Related]
2. Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system.
Gabe MBN; van der Velden WJC; Gadgaard S; Smit FX; Hartmann B; Bräuner-Osborne H; Rosenkilde MM
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6(Suppl 6):122-132. PubMed ID: 31299132
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant.
Yammine L; Picatoste B; Abdullah N; Leahey RA; Johnson EF; Gómez-Banoy N; Rosselot C; Wen J; Hossain T; Goncalves MD; Lo JC; Garcia-Ocaña A; McGraw TE
Mol Metab; 2023 Dec; 78():101831. PubMed ID: 37925022
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes.
Jacobi SF; Khajavi N; Kleinau G; Teumer A; Scheerer P; Homuth G; Völzke H; Wiegand S; Kühnen P; Krude H; Gong M; Raile K; Biebermann H
Diabetes Obes Metab; 2019 May; 21(5):1168-1176. PubMed ID: 30784161
[TBL] [Abstract][Full Text] [Related]
5. Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the
Bowker N; Hansford R; Burgess S; Foley CN; Auyeung VPW; Erzurumluoglu AM; Stewart ID; Wheeler E; Pietzner M; Gribble F; Reimann F; Bhatnagar P; Coghlan MP; Wareham NJ; Langenberg C
Diabetes; 2021 Nov; 70(11):2706-2719. PubMed ID: 34426508
[TBL] [Abstract][Full Text] [Related]
6. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function.
Renner S; Fehlings C; Herbach N; Hofmann A; von Waldthausen DC; Kessler B; Ulrichs K; Chodnevskaja I; Moskalenko V; Amselgruber W; Göke B; Pfeifer A; Wanke R; Wolf E
Diabetes; 2010 May; 59(5):1228-38. PubMed ID: 20185813
[TBL] [Abstract][Full Text] [Related]
7. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin.
Sauber J; Grothe J; Behm M; Scherag A; Grallert H; Illig T; Hinney A; Hebebrand J; Wiegand S; Grüters A; Krude H; Biebermann H
Eur J Endocrinol; 2010 Aug; 163(2):259-64. PubMed ID: 20516203
[TBL] [Abstract][Full Text] [Related]
8. A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk.
Torekov SS; Harsløf T; Rejnmark L; Eiken P; Jensen JB; Herman AP; Hansen T; Pedersen O; Holst JJ; Langdahl BL
J Clin Endocrinol Metab; 2014 Apr; 99(4):E729-33. PubMed ID: 24446656
[TBL] [Abstract][Full Text] [Related]
9. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
[TBL] [Abstract][Full Text] [Related]
10. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling.
Tseng CC; Zhang XY
Endocrinology; 2000 Mar; 141(3):947-52. PubMed ID: 10698169
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
Lewis JT; Dayanandan B; Habener JF; Kieffer TJ
Endocrinology; 2000 Oct; 141(10):3710-6. PubMed ID: 11014226
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
13. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
[TBL] [Abstract][Full Text] [Related]
14. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
[TBL] [Abstract][Full Text] [Related]
15. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
Mohammad S; Patel RT; Bruno J; Panhwar MS; Wen J; McGraw TE
Mol Cell Biol; 2014 Oct; 34(19):3618-29. PubMed ID: 25047836
[TBL] [Abstract][Full Text] [Related]
16. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice.
Perry RA; Craig SL; Ng MT; Gault VA; Flatt PR; Irwin N
Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419875453. PubMed ID: 31548798
[TBL] [Abstract][Full Text] [Related]
18. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.
Shalaby SM; Zidan HE; Shokry A; Saeed J; El-Sokkary RH
J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28744963
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular biology of the GIP receptor.
Greenwell AA; Chahade JJ; Ussher JR
Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
[TBL] [Abstract][Full Text] [Related]
20. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
